Dermata Therapeutics, Inc (DRMA) Misses Q3 EPS by 165c

November 14, 2025 5:28 PM

Dermata Therapeutics, Inc (NASDAQ: DRMA) reported Q3 EPS of ($1.65).

For earnings history and earnings-related data on Dermata Therapeutics, Inc (DRMA) click here.